MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY

MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY

Mucolytic drugs, particularly, direct action mucolytics with acetylcysteine derivatives among them, are included in the complex therapy of the bronchopulmonary dysplasia exacerbations. However, data on application effectiveness and safety of such a therapy with chronic bronchopulmonary diseases in c...

Full description

Saved in:
Bibliographic Details
Main Authors: I. V. Davydova, T. V. Turti, E. P. Zimina, V. V. Altunin
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2012-10-01
Series:Педиатрическая фармакология
Subjects:
respiratory distress syndrome
bronchopulmonary dysplasia
respiratory function
acute respiratory viral infection
bronchoobstructive syndrome
mucociliary clearance
acetylcysteine
Online Access:https://www.pedpharma.ru/jour/article/view/287
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mucolytic drugs, particularly, direct action mucolytics with acetylcysteine derivatives among them, are included in the complex therapy of the bronchopulmonary dysplasia exacerbations. However, data on application effectiveness and safety of such a therapy with chronic bronchopulmonary diseases in children of 0–2 years of age are few and contradictory. The article contains proprietary clinical functional data on application of acetylcysteine in granules for the syrup preparation in the treatment of children bronchopulmonary dysplasia.
ISSN:1727-5776
2500-3089

Similar Items